Disease / condition

Type 1 Diabetes Mellitus clinical trials

Free access to 514 studies·10+ countries·Updated daily43 recruiting
514
Total trials
10+
Countries
10+
Sponsors
43
Recruiting
By phase
N/A275
Phase 157
Phase 252
Phase 342
Early Phase 137
By status
Completed354
Recruiting43
Unknown31
Terminated29
Not yet recruit...28
Top countries
United States of America214
Germany20
Canada20
United Kingdom18
Australia16
Top sponsors
University of Virg...27
Sanofi25
Eli Lilly and Comp...15
Sansum Diabetes Re...11
National Institute...9
Recent trials
Latest clinical trials for Type 1 Diabetes Mellitus
2014-004640-35
Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old. (Lantus-P-CN)
Sanofi
NCT06411548Not yet recr...
Insulearn Feasibility With MDI
University of VirginiaUnited States of America
NCT06390371Recruiting
Implementing the Spotlight AQ Platform in Adolescent/ Young Adult (16-25 Years Old) Type 1 Diabetics (T1D)
Children's Mercy Hospital Kans...United States of America
NCT06361680·Phase 1Not yet recr...
Effect of Coenzyme Q10 on Diabetic Children
Assiut University
NCT06272695·Phase 1Recruiting
Glucagon Rescue of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes Treated With Volagidemab
REMD Biotherapeutics, Inc.United States of America
NCT06139913Completed
Aerobic Exercise on Fitness Score and Blood Glucose Level in Adolescents Girls With Diabetes Mellitus
MTI UniversityEgypt
NCT06152042·Phase 2Not yet recr...
Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes Mellitus
Biomea Fusion Inc.
NCT06111586·Phase 2Recruiting
FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)
SanofiCanada,United States of America
NCT06081231Recruiting
Android Artificial Pancreas System Use Among Patients With Type 1 Diabetes Mellitus in China
Third Affiliated Hospital, Sun...China
2022-003318-35Ongoing
A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of VX-264 in Subjects With Type 1 Diabetes Mellitus
Vertex Pharmaceuticals Incorpo...
NCT06151821Completed
Examining the Influence of Guided Meditation on Diabetes-related Distress and Glycemic Control
Shifa International HospitalPakistan
UMIN000051372Completed
Assessing the Impact of Mobile-Based Interventions Provided by Pharmacists on Glycemic Control in Adolescent Patients with Type 1 Diabetes Mellitus in Pakistan
Shifa Hospital Lahore PakistanAsia
NCT05649553Not yet recr...
The Effect of Digital Game-Based Diabetes Education on Quality of Life of Children With Type 1 Diabetes Mellitus
Pamukkale UniversityTurkey
NCT05574335·Phase 1/2Not yet recr...
Siplizumab in T1DM
National Institute of Allergy ...United States of America
NCT05272059·Phase 1Not yet recr...
Multiple Ascending Dose Study of MHS552 in Adults With Type 1 Diabetes Mellitus
Novartis Pharmaceuticals
NCT05179135Completed
Effects of Postprandial Exercise on Glycaemia and Metabolism in People With Type 1 Diabetes
University Hospital, GhentBelgium
NCT05067270·Phase 1Completed
A Study of Infusion Site Pain After Infusion of Excipients in Participants With Type 1 Diabetes Mellitus
Eli Lilly and CompanyGermany
NCT05059860Not yet recr...
Dexcom Hybrid Closed Loop Insulin Pump Study in Type 1 Diabetes
NHS Lothian
NCT05022875Recruiting
Effectiveness of The Health Care CEO App for T1D
Chang Gung UniversityTaiwan
2021-001459-15Ongoing
Immune response to COVID-19 Vaccination in people with Diabetes Mellitus - COVAC-DM study
Medical University of Graz
About this record

Access comprehensive clinical trial information for Type 1 Diabetes Mellitus through Pure Global AI's free database. This collection includes 514 clinical trials across multiple phases including N/A, Phase 1, Phase 2. Currently, 43 trials are actively recruiting participants.

Research for Type 1 Diabetes Mellitus is being conducted in United States of America, Germany, Canada and 7+ other countries. Leading sponsors include University of Virginia and Sanofi. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 514 clinical trials studying Type 1 Diabetes Mellitus, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include University of Virginia, Sanofi, Eli Lilly and Company, among others.